Brain Penetration

LAUSANNE, Switzerland, August 20, 2026 AC Immune SA announced positive preliminary Phase 1 clinical data for ACI-19764, its wholly...

Waltham, Massachusetts, July 28, 2026 Dyne Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has cleared...

Ramat-Gan, Israel, July 28, 2026 Galmed Pharmaceuticals Ltd. has announced a significant advancement in the development of Aramchol orally...